You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
A glance on current progress of innovative drug R&D in china
- In: FIP KEYNOTE: A GLANCE ON CURRENT PROGRESS OF INNOVATIVE DRUG R&D IN CHINA on Wednesday, 16 April 2014, 09:00-10:00
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: SANG, Guowei (Chinese Pharmaceutical Association, Beijing, China)
- Abstract:
Prior to the China 10th 5-Year Plan (2001-2005), the most of Chinese pharmaceutical companies basically only focused on the generic drug development as only a few of them are affordable and willing to invest on innovative drug development. With the new national policy on Innovation Society promulgated by the State Council since 2005, the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026